Jula Inrig
Fortune : 6 M $ au 30/06/2026
Fortune : 6 M $ au 30/06/2026
Jula Inrig is currently Chief Medical Officer, EVP-Research & Development at Travere Therapeutics, Inc., starting in 2026.
Former positions include Director at Kidney Health Initiative from 2013 to 2018 and Global Head-Renal Center of Excellence at IQVIA, Inc. from 2017 to 2021.
Education includes undergraduate studies at California State University-Sacramento, a doctorate from Loma Linda University, and graduate studies at Duke University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/06/2026 | 112 770 ( 0,12 % ) | 6 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 04/01/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| IMS HEALTH, INC. | Corporate Officer/Principal | 01/12/2021 |
Kidney Health Initiative | Directeur/Membre du Conseil | 01/01/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
IQVIA, Inc.
IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California State University-Sacramento
California State University-Sacramento Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loma Linda University
Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Kidney Health Initiative |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national